Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 7 of 7 for “"Lewy body disease"”.

  1. Substrate Selection by the 20S Proteasome and Implications in Disease Pathogenesis

    Alpha-synuclein is a major component of Lewy bodies, large insoluble protein aggregates, found in various regions of the brain in patients with Parkinson’s disease, diffuse Lewy body disease, and the Lewy body variant of Alzheimer’s disease. Within Lewy bodies, several modifications of …

    utswmed Repository record for Substrate Selection by the 20S Proteasome and Implications in Disease Pathogenesis (opens in a new tab)

  2. Neuropathological findings and staging in dementia

    … that on a neuropathological basis, Alzheimer’s disease (AD) is the most common dementia disorder, followed by vascular dementia (VaD) and mixed AD+VaD. Also, in a significant number of patients, the clinical dementia subtype diagnosis does not correspond with the neuropathological findings. …

    lund Repository record for Neuropathological findings and staging in dementia (opens in a new tab)

  3. Metabolism of Alpha-Synuclein by the 20S Proteasome

    Parkinson's disease is one of several common neurodegenerative disorders that are related by the intracellular aggregation of the neuronal protein alpha-synuclein (alphaSyn) that normally associates with synaptic vesicles. Within the aggregates, a fraction of alphaSyn is truncated at the C-termini, …

    utswmed Repository record for Metabolism of Alpha-Synuclein by the 20S Proteasome (opens in a new tab)

  4. Dementia with Lewy bodies —an Investigation of Cause and Consequence

    Dementia with Lewy bodies (DLB) is today considered to be the second most common primary neurodegenerative dementia after Alzheimer’s disease. However, the disease has only been a clearly defined entity for 13 years. Due to its recent recognition, DLB is still not as extensively studied as are …

    lund Repository record for Dementia with Lewy bodies —an Investigation of Cause and Consequence (opens in a new tab)

  5. Implications of Advanced Glycation Endproducts in Oxidative Stress and Neurodegenerative Disorders

    … deposits in Alzheimer's (AD) and Parkinson's disease (PD) and dialysis-related amyloidosis. AGE-modified proteins are also involved in the complications of diabetes. AGEs accumulate in the the ß-amyloid plaques and neurofibrillary tangles (NFT) associated with AD and in the Lewy bodies …

    wurz-thes Repository record for Implications of Advanced Glycation Endproducts in Oxidative Stress and Neurodegenerative Disorders (opens in a new tab)

  6. Adapting Behavioral Interventions to Better Support Alzheimer's Disease and Lewy Body Dementia Care Partners Based on Their Unique Needs and Differences

    Care partners of individuals with Alzheimer's disease (AD) and Lewy body dementia (LBD) are typically family members or friends. They often experience physical and psychological strain associated with caregiving. Hence, the long-term goal is to improve the physical and psychological health and …

    utswmed Repository record for Adapting Behavioral Interventions to Better Support Alzheimer's Disease and Lewy Body Dementia Care Partners Based on Their Unique Needs and Differences (opens in a new tab)

  7. Markers of Prognosis in Neurodegenerative Dementia

    … provide information about course and outcome of disease, e.g. predict time to a given endpoint or rate of progression due to disease in patients or subgroups of patients. Prognostic markers could be targeted to apply during the entire clinical course or just during distinct stages of the disease. …

    lund Repository record for Markers of Prognosis in Neurodegenerative Dementia (opens in a new tab)